Current Psychiatry Reports

, Volume 14, Issue 6, pp 687–695 | Cite as

Integrating Bipolar Disorder Management in Primary Care

  • Amy M. Kilbourne
  • David E. Goodrich
  • Allison N. O’Donnell
  • Christopher J. Miller
Bipolar Disorders (MA Frye, Section Editor)


There is growing realization that persons with bipolar disorder may exclusively be seen in primary (general medical) care settings, notably because of limited access to mental health care and stigma in seeking mental health treatment. At least two clinical practice guidelines for bipolar disorder recommend collaborative chronic care models (CCMs) to help integrate mental health care to better manage this illness. CCMs, which include provider guideline support, self-management support, care management, and measurement-based care, are well-established in primary care settings, and may help primary care practitioners manage bipolar disorder. However, further research is required to adapt CCMs to support complexities in diagnosing persons with bipolar disorder, and integrate decision-making processes regarding medication safety and tolerability in primary care. Additional implementation studies are also needed to adapt CCMs for persons with bipolar disorder in primary care, especially those seen in smaller practices with limited infrastructure and access to mental health care.


Bipolar disorder Mood disorder Co-occurring conditions Primary care Integrated care Collaborative care Chronic Care Model CCM Screening Diagnosis Treatment Access Mental health services Psychiatry 


Bipolar disorder is a complex and chronic condition associated with significant functional impairment, high health care costs, and mortality, particularly from cardiovascular disease (CVD), and represents a substantial public health problem in primary care settings. While it has been well-known that primary care is the de facto treatment setting for patients with unipolar depression [1, 2], there is increased awareness that many patients with bipolar disorder are seen exclusively in primary care, due to a lack of access to specialty mental health care services and the stigma associated with receiving care in a mental health setting [2, 3]. Chronic mood disorders often go unrecognized and undertreated in primary care settings; however, the problem is particularly acute for patients with bipolar disorder. Lack of accurate and efficient screening and diagnostic protocols continue to be barriers to establishing a differential diagnosis between unipolar depression and bipolar disorder and to initiating appropriate evidence-based treatments.

Despite the proliferation of psychopharmacology, outcomes for persons with bipolar disorder remain suboptimal. Until recently, treatment guidelines have ignored real world settings where patients typically present with complex treatment issues that vary by symptom severity, presence of comorbid conditions, phase of treatment, and the need to balance treatment efficacy with consideration for side effects and safety [4•, 5•]. Adjunctive psychosocial treatments including psychotherapy or psychoeducation are recommended for persons with bipolar disorder in addition to pharmacotherapy [6, 7], but to date these modalities have not been deployed in routine primary care settings.

This paper reviews the current research regarding the management of bipolar disorder in primary care. To assess the state of the art, key articles found through Pubmed were reviewed (including empirically-based research, reviews, and guidelines/consensus statements) that were published since January 2011. Keywords used in this review included “bipolar disorder,” “bipolar,” “mania,” “primary care,” and “medical.” A total of 34 articles were identified as directly relevant to this literature review [2, 4•, 5•, 8, 9•, 10, 11••, 12•, 13, 14, 15, 16•, 17, 18, 19•, 20, 21, 22, 23, 24, 25•, 26, 27, 28••, 29•, 30, 31, 32, 33, 34, 35, 36, 37•, 38]. Although a number of excellent clinical review articles [28••, 29•] have been published within the past few years on the management of bipolar disorder in primary care, the focus of this review was to examine the most current literature published within the last 18 months.

Based on this review of the literature, the following emergent issues were identified that preclude effective treatment of bipolar disorder in primary care: 1) methodological issues in screening and diagnosing bipolar disorder, 2) need for tailored treatment guidelines for primary care practitioners, 3) new evidence-based treatment practices such as collaborative/chronic care models (CCMs) that may help primary care providers in managing bipolar disorder, and 4) lack of implementation strategies to effectively implement CCMs in primary as well as mental health care settings, especially across network model or rural practices.

Unrecognized Burden of Bipolar Disorder in Primary Care

National studies of the U.S. population estimate the lifetime prevalence rates of bipolar spectrum disorders (a.k.a. bipolar disorder) to be 6.4 % compared to 16.6 % for major depressive disorder [39]. There is a growing realization that primary care is the de facto site of care for persons with bipolar disorder. Evidence suggests that between 10 to 38 % of patients with bipolar disorder are treated exclusively in primary care settings due to barriers to accessing specialty mental health services and the stigma associated with receipt of care from such specialty providers [2, 3, 40].

Subthreshold bipolar diagnoses, such as bipolar disorder not otherwise specified and cyclothymia, are not only prevalent and clinically significant but also go largely untreated in primary care [41]. In a nationally representative sample of U.S. adults diagnosed with depression, 40 % of participants also had a history of subthreshold bipolar manic symptoms [41]. Fewer than half of patients with a lifetime history of a bipolar spectrum disorders receive any kind of mental health treatment [42]. Notably, the role impairment associated with these subthreshold disorders is similar to that of bipolar I disorder [42] and present with significant psychiatric comorbidity and symptom severity predisposing them to an increased risk for suicide and general medical conditions.

While unipolar depression is more common, patients with bipolar disorder incur the most health care costs of any mental illness [43]. The annual direct and indirect costs for treating bipolar disorder have risen dramatically to $151 billion dollars [44] due in part to a reliance on expensive pharmacological treatments. Prior research has estimated that up to 70 % of direct treatment costs for mood disorders are generated outside the mental health sector, notably in primary care [45]. In a recent analysis of an employer-based healthcare plan, patients with bipolar disorder had higher total health care utilization costs compared to patients diagnosed with depression, asthma, and coronary artery disease, and total costs were comparable to patients with diabetes [18]. The key driver of these costs are likely comorbid cardiometabolic disorders (e.g., obesity, diabetes, heart disease) [46•], and costs to treat these conditions were higher when comorbid with bipolar disorder. For example, in a recent population-based analysis of health claims in Taiwan, researchers found patients with bipolar disorder had total annual medical costs that were 11 times higher than matched patients from the general population without bipolar disorder [19•]. This cost differential was attributed primarily to significantly greater cost per patient for treating cardiovascular disease or cardiometabolic risk factors than comparison patients unburdened by bipolar mood symptoms. Increased use of psychotropic medications that increase cardiovascular disease risk factors, especially in primary care settings [40], adds further complexity to the clinical decision making providers must consider in routine care settings.

It is also well-known that bipolar disorder is associated with significant psychiatric comorbidity that further complicates the course of treatment for providers [47, 48]. Over 70 % of persons with a bipolar disorder report a psychiatric comorbidity [42], with anxiety and substance abuse disorder having a lifetime prevalence risks of 83 % and 60 %, respectively [5•, 41, 43, 49, 50, 51]. Risk of suicide is 20 times higher among individuals with bipolar disorder than in the general population which therefore requires ongoing assessment of risk factors to prevent adverse outcomes during serious mood episodes [52]. Hence, primary care interventions for bipolar disorder need to take into account these co-occurring conditions and risk factors.

Bipolar Disorder Case Finding in Primary Care

Improving care for persons with bipolar disorder seen in primary care settings requires effective panel management and attention to accurate case finding and measurement-based care strategies. A staple of chronic illness care in primary care settings, panel management involves primary care teams proactively identifying and reaching out to high-risk populations in their practice to improve quality of care and outcomes [53, 54]. To achieve this objective, primary care teams often establish patient registries based on established entry (i.e., diagnostic) criteria, in order to monitor key risk factors, medication side effects, symptoms, and treatment response among a high risk patient population so that treatment plans can be adjusted. Panel management allows a practice to improve preventive and chronic care management for a high-risk population while also improving work flow so that physicians have more time to spend on complex functions. Primary care management of depression was revolutionized by the implementation of depression patient registries and ongoing monitoring of symptoms using the Patient Health Questionnaire-9 (PHQ-9) as a diagnostic and symptom severity tool [54, 55].

In contrast, accurate case finding and symptom assessment for bipolar disorder in primary care is more difficult given the lack of a screening and diagnostic protocol that is practical yet valid for routine use. A number of challenges exist in the accurate diagnosis of bipolar disorder in primary care settings. First, depression is the most frequently occurring mood symptom experienced by patients with bipolar disorder and these patients are more likely to present with depressive symptoms in routine practice. Second, many patients have poor insight or recall of manic symptoms or episodes which makes differential diagnosis difficult. Third, many bipolar disorder symptoms are mistaken for other psychiatric disorders such as anxiety and personality disorders [36, 56]. Misdiagnosis and consequent prescribing of contraindicated (e.g., antidepressant monotherapy) or unnecessary medications for persons with bipolar disorder can exacerbate the frequency and severity of mood symptoms as well as promote treatment resistance to appropriate medications [4•, 55]. A recent retrospective cohort study examining administrative health claims found that 18 % of patients received the diagnosis of unipolar depression after receiving a bipolar diagnosis, which led to increased treatment costs and resulted in poorer outcomes for the patient [56].

Primary care physicians often lack the time and training to conduct lengthy clinical interviews to correctly diagnose bipolar disorder. While considered the gold standard, the Structured Clinical Interview for DSM-IV (SCID) as well as other diagnostic assessment such as the Mini Neuropsychiatric Interview (MINI) are impractical for primary care because of their length or need for a mental health clinician to administer. Hence, a number of brief screening and symptom assessment tools have been developed for bipolar disorder (see Table 1). The Mood Disorder Questionnaire (MDQ), Hypomania Checklist (HCL-32) and Bipolar Spectrum Diagnostic Scale (BSDS) are the three most widely used screening tools for bipolar disorder and have been employed in a number of recent cross-sectional studies to examine the level of undetected bipolar spectrum disorders [10, 24, 29•, 36, 56, 57]. Yet, while many tout the reliability of currently available screening tools, others argue that none are reliable enough to be used alone for diagnosing bipolar disorder in clinical practice [29•, 58•, 59]. Hence, any screening tools should be linked to subsequent confirmatory diagnosis by a mental health specialist or supported with other information such as family history or clinical interview. Another promising strategy to identifying bipolar disorder might be to use healthcare system databases and electronic medical record systems to identify patients with depressive diagnoses and potential risk factors (e.g., high utilization, substance abuse, anxiety disorder). Those screening positive would then receive a confirmatory diagnosis from their physician or a patient-completed self-report measure, an approach that is currently being pilot tested [9•, 60].
Table 1

Widely-used measures to screen for bipolar disorders



Study population(s)




Mood Disorder Questionnaire (MDQ) [79, 80, 81, 82]

13-item, paper & pencil self-report checklist used to screen for lifetime hx of bipolar spectrum disorder administered by physician, RN, or trained medical assistant

Mental health, primary care outpatients

Sensitivity ranges from .28 to .73


Does not track symptom changes or severity over time


Specificity = .90–.97 (.76 for BD II)

Easy to administer to patients & score (phone or face-to-face)

Better for detecting BD I than BD II or NOS


Possible misclassification (e.g., borderline personality disorder)

Bipolar Spectrum Diagnostic Scale (BSDS) [83]

20-item “narrative-based” patient self-completed scale to identify symptoms across BD spectrum. The 1st part includes a 19-item checklist; 2nd part includes multiple choice item to respond how a scenario applies to current state

Mental health outpatients

Sensitivity ranges from .79 (BD II) to .76 (BD I)

Good sensitivity and specificity to identify and discriminate BD spectrum disorders

Lacks normative data for use in the general population


Specificity = .85

Suggested as a complementary measure to MDQ

Not useful for longitudinal assessment

Hypomania/Mania Symptom Checklist-32 (HCL-32) [57, 84, 85]

32-item screening instrument for Bipolar II

Mental health outpatients

Sensitivity = .80–.85

Assesses most mania symptoms

Does not assess other relevant BD symptoms

Yes/no checklist format to endorse relevant symptoms

Specificity = .51–.79

Adapted for multi-lingual use

Not clear that it can differentiate BD subtypes


Not tested in primary care patients

Provisional Diagnostic Instrument (PDI-4) [38]

17-item patient self-report screening instrument to screen for MDE, GAD, ADHD, and past/present mania

Primary care outpatients

Sensitivity (mania) = .83

Brief measure for primary care patients


4 items for each of the four diagnostic categories with individual items scored on 0–4 scale from “Never” to “All the Time”. The 17 item interference with daily function must score a 3 or higher for ADHD and 2 or higher for other diagnoses

Specificity (mania) = .82

Identifies multiple non-psychotic disorders seen in primary care

Piloted on 25 patients diagnosed with bipolar


Validated against other clinical interview and self-report measures

Does not track symptom change over time


Further cross-validation with community-based samples needed

New Guidelines Focus on Complex Care Management

In addition to lack of robust screening tools, primary care providers also lack regular access to up-to-date evidence-based bipolar disorder treatment guidelines that provide clear treatment algorithms to address the complex clinical presentations of most patients diagnosed with bipolar disorder [37•]. Pharmacotherapies, notably mood stabilizers such as lithium, anticonvulsants, and some second-generation antipsychotics, continue to be the primary basis for managing bipolar disorder [6, 7, 29•]. More recent guidelines for bipolar disorder focus on more complex care issues, notably management of co-occurring conditions and the need for adjunctive psychosocial treatment [4•, 28••], which is increasingly being used in primary care settings in general. Malhi and colleagues provide a clear evidenced-based guide of treatment strategies for bipolar disorder, paying close attention to maintenance strategies to prevent relapse. Building on existing guidelines [61] to manage pharmacological safety monitoring they help providers understand how to balance the efficacy, safety and tolerability of treatment decision-making using an approach that promotes shared decision making between patient and provider. The 2012 release of treatment guidelines for mood disorders by the Canadian Network for Mood and Anxiety Treatments (CANMAT) also gives providers evidenced-based recommendations on addressing a number of complex treatment challenges related to co-occurring conditions, including: anxiety disorders, attention deficit/hyperactivity disorders, personality disorders, metabolic disorders, and other medical conditions [7, 30, 32, 33, 34, 35, 62, 63].

Still, many primary care providers may feel uncomfortable prescribing bipolar disorder medications, particularly when it comes to antipsychotics, due to a lack of knowledge and training, as well as higher rates of suicide, and controversies around prescribing drugs [26]. Therefore, it is vital to develop practical tools based on these guidelines to assist providers with treating bipolar disorder [9•, 25•], taking into account potential side-effects to psychotropic drugs and co-morbid conditions in addition to direct treatment.

Collaborative/Chronic Care Models for Bipolar Disorder

In addition to the need for valid and systematic case finding tools and practical guideline protocols, managing bipolar disorder in primary care should also include a psychosocial component. More recent bipolar disorder treatment guidelines increasingly recognize the role of effective adjunctive psychosocial interventions that promote patient activation to increase self-management of bipolar symptoms and coping strategies [6, 64]. Similarly, collaborative chronic care models (CCMs) have been widely studied in primary care settings as a means to improve management and outcomes of chronic illnesses. The six core elements of CCMs established by Wagner and colleagues [65, 66] can be found in Table 2. CCMs, which typically include at least three of the six core components above, can serve as an ideal framework to help primary care practitioners manage bipolar disorder. In a recent meta-analysis [16•], CCMs were found to be effective in treating chronic medical and mental illnesses across a wide range of mental disorders including bipolar disorder [67, 68, 69] at little to no net healthcare cost. CCMs for bipolar disorder were also recommended in two recent guidelines as models of care to promote guideline adherence and self-management in addition to pharmacotherapy (54, 55). Moreover, treatment with the CCM has been found effective among patients with bipolar and co-occurring substance use disorders.
Table 2

Collaborative/ chronic care model components adapted for managing bipolar disorder in primary care settings



Adaption for bipolar disorder in primary care

Clinical information systems

Use of panel management for identifying persons at risk of poor outcomes for ongoing follow-up and chronic illness management

Clinical registry for screening, provider confirmation of bipolar disorder diagnosis, and ongoing follow-up with additional information on family history and safety plans

Measurement-based care (i.e., ongoing symptom monitoring) to assess patient progress

Ongoing assessments of mood symptoms, suicidality, functioning, and cardiometabolic measures associated with psychotropic medications

Delivery system redesign

Provider teams meet to organize care that is anticipatory rather than reactive through assigning roles and establishing work flows for case finding, registry development, self-management, care management, and access to mental health specialists and practice guideline tools

Access to mental health support services in addition to care management for non-medical needs


Use of mental health specialists to carry out clinical practice guidelines to free up physician time for advanced clinical care activities

Decision (guideline) support

Practical tools and guideline summaries for generalists to help with treatment decision-making, often in collaboration with a non-physician care manager

Team consultations with mental health specialists on non-routine diagnostic or treatment issues, with a particular focus on monitoring for side effects and toxicity around cardiovascular and cardiometabolic risk factors

Patient self-management support

Psychoeducation and health coaching with a focus on symptom coping, problem-solving, and medication adherence strategies with an emphasis on active participation in provider care plan decision-making

Frequent self-management or psychosocial sessions as needed to cover identification of early warning signs of bipolar episodes, impact of stigma, and other topics related to bipolar disorders such as substance use, anxiety, psychosis, anger/irritability, metabolic risk using onsite, phone, or internet delivery

Community resource linkages

Support for social and clinical needs in addition to the health care setting

Referral to other community social services such as housing, peer networks, substance use providers, etc.

Leadership support

Organization-level leadership and tangible resources to support CCM goals and practices

Provision of adequate clinical staff for CCM training and implementation; support from key non-clinical services such as informatics; championship by organization leadership, optimally with a commitment to sustainability after the research phase of the intervention ends

To date, CCMs have primarily been implemented for persons with bipolar disorder in mental health specialty settings [67, 68, 69]. Two ongoing randomized controlled trials are adapting the CCM for bipolar disorder in primary care settings [11••, 14, 17]. Table 2 provides an overview of how CCMs can be adapted to manage bipolar disorder in primary care. Notably, the bipolar CCM should include a more intensive psychosocial self-management program, preferably involving weekly sessions in addition to care manager contacts and linkages [13]. These weekly self-management programs have been designed to guide patients in managing their symptoms and work collaboratively with their providers, and should have a recovery-oriented approach by focusing on the participant’s personal goals and coping strategies [17]. Because bipolar disorder is often associated with substance use and other co-occurring conditions, the self-management component should also cover these conditions. In contrast, self-management programs for depression and other chronic illnesses are typically less intensive, often relying on briefer contacts with a central focus on medication management. In addition, the bipolar CCM needs to include not only guidance for mood stabilizer medications but additional information on monitoring for side effects and toxicity, notably for cardiovascular and cardiometabolic risk factors. These guidelines should come in the form of simplified tools such as notecards or clinical reminder systems [9•, 69]. Finally, bipolar disorder is by definition a chronic illness, where patients often face recurring manic and depressive episodes over the lifespan—as opposed to depression which may or not be recurrent or chronic. Hence, care managers should be able to not only access psychiatrists for guidance on treatment decision-making for more complex cases, but also to access other mental health providers such as licensed social workers or case managers to support other mental health specialty services.

Conclusions and Future Directions

Overall, given the increased awareness that persons with bipolar disorder seek care from primary care providers, there are prime opportunities for further research in adapting well-established primary care models such as the CCM for managing bipolar disorder. While CCMs provide a practical model for managing mental disorders in primary care settings, self-management support, care management, and provider guideline support will have to be enhanced to make it feasible to manage bipolar disorder in primary care. CCMs can and should be adapted for bipolar disorder in primary care because it is an ideal model in which to integrate mental health services. Moreover, bipolar disorder is often considered a tracer condition for integrated mental health care because of the wide range of symptoms and functioning experienced by patients, substantial prevalence of co-occurring conditions, and disproportionate numbers of deaths due to suicide or medical conditions (e.g., cardiovascular disease-CVD).

Furthermore, as with most CCM studies, bipolar disorder CCMs have primarily been implemented in closed health care systems or staff-model health plans. However, recent research has determined that the vast majority of primary care and behavioral health practices providing commercially insured care are far too small to implement such models. For example, up to 85 % of Americans with bipolar disorder are managed in solo or small practices comprising fewer than 20 providers, which often do not have the capacity to implement CCMs [70]. Hence, additional implementation studies need to examine how to bring CCMs to persons with bipolar disorder seen across routine primary care settings that vary by size, intervention mode, and provider mix. For example, telehealth and e-health interventions may help support remote care for patients and support self-management [60, 71, 72, 73, 74, 75, 76], especially for small and solo practices [70]. The VA National TeleMental Health Center is currently conducting a clinical roll-out of a Bipolar CCM TeleHealth Program, based on previously established CCMs for bipolar disorder [77, 78]. Ultimately, given the desire for widespread adoption of telehealth and similar technologies as well as the need to address disparities in access to mental health care in smaller and more rural practices, adapting CCMs for bipolar disorder may inform the further implementation of integrated care into primary care settings across a wide range of mental health disorders.



This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development [CSRD S06], the VA Health Services Research and Development Center for Organization, Leadership, and Management Research (COLMR), the National Institute of Mental Health [RO1 MH 79994 and R01 74509] and the University of Michigan Comprehensive Depression Center (Director’s Innovation Fund). The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs.


A.M. Kilbourne is the author of the workbook Overcoming Bipolar Disorder: A Comprehensive Workbook for Managing Your Symptoms & Achieving Your Life Goals (New Harbinger Publications, Inc., 2008), which was the basis for many of the current study interventions cited and for which she receives royalties; D.E. Goodrich: none; A.N. O’Donnell: none; CJ. Miller: none.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):629–40.PubMedCrossRefGoogle Scholar
  2. 2.
    Reilly S, Planner C, Hann M, Reeves D, Nazareth I, Lester H. The role of primary care in service provision for people with severe mental illness in the United kingdom. PLoS One. 2012;7(5):e36468.PubMedCrossRefGoogle Scholar
  3. 3.
    Kilbourne AM, Goodrich D, Miklowitz DJ, Austin K, Post EP, Bauer MS. Characteristics of patients with bipolar disorder managed in VA primary care or specialty mental health care settings. Psychiatr Serv. 2010;61(5):500–7.PubMedCrossRefGoogle Scholar
  4. 4.
    • Malhi GS, Bargh DM, McIntyre R, Gitlin M, Frye MA, Bauer M, et al. Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder. Bipolar Disord. 2012;14 Suppl 2:1–21. A comprehensive and practical review of clinical recommedations for treating each phase of bipolar disorder with emphasis on helping providers balance issues of treatment efficacy, safety, and tolerability with real world issues of managing complex comorbidity and shared decision making. PubMedCrossRefGoogle Scholar
  5. 5.
    • McIntyre RS, Rosenbluth M, Ramasubbu R, Bond DJ, Taylor VH, Beaulieu S, et al. Managing medical and psychiatric comorbidity in individuals with major depressive disorder and bipolar disorder. Ann Clin Psychiatry. 2012;24(2):163–9. An overview of the CANMAT task force consensus and evidence-based recommendations for treating comorbid conditions in patients with major depressive disorder or bipolar disorder. PubMedGoogle Scholar
  6. 6.
    Department of Veterans Affairs, Department of Defense. VA/DoD Clinical Practice Guideline for Management of Bipolar Disorder in Adults. 2010. Accessed July 1 2012.
  7. 7.
    Yatham LN, Kennedy SH, Schaffer A, Parikh SV, Beaulieu S, O’Donovan C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 2009;11(3):225–55.PubMedCrossRefGoogle Scholar
  8. 8.
    Smith DJ, Griffiths E, Kelly M, Hood K, Craddock N, Simpson SA. Unrecognised bipolar disorder in primary care patients with depression. Br J Psychiatry. 2011;199(1):49–56.PubMedCrossRefGoogle Scholar
  9. 9.
    • Gill JM, Chen YX, Grimes A, Klinkman MS. Using electronic health record-based tools to screen for bipolar disorder in primary care patients with depression. J Am Board Fam Med. 2012;25(3):283–90. Authors find that EHR-based tools can facilitate the diagnosis and prescription of mediction for bipolar depression through electronic screening and decision support tools. PubMedCrossRefGoogle Scholar
  10. 10.
    Rouillon F, Gasquet I, Garay RP, Lancrenon S. Screening for bipolar disorder in patients consulting general practitioners in France. J Affect Disord. 2011;130(3):492–5.PubMedCrossRefGoogle Scholar
  11. 11.
    •• Kilbourne AM, Goodrich DE, Clogston J, Bauer MS, Waxmonsky JA, VanDeusen Lukas C, et al. Randomized controlled trial of the Replicating Effective Programs implementation framework: the Recovery-Oriented Collaborative Care Study. Implement Sci. 2012; In review. Rationale and description of a randomized effectiveness trial comparing two different implementation strategies to deliver an evidence-based chronic care model for bipolar disorder in community settings that optimizes fidelity to active intervention components while allowing for local practice adaptation. Google Scholar
  12. 12.
    • Kilbourne AM, Goodrich DE, Lai Z, Post EP, Schumacher K, Bramlet M, et al. Randomized trial to reduce cardiovascular disease risk for patients with bipolar disorder: the Self-Management Addressing Heart Risk Trial (SMAHRT). J Clin Psychiatr. 2012; In review. The second randomized controlled trial demonstrating the effectiveness of an integrated chronic care model for bipolar depression to reduce blood pressure and manic symptoms compared to usual treatment in a VA healthcare setting. Google Scholar
  13. 13.
    Kilbourne AM, Goodrich DE, Lai Z, Clogston J, Bauer MS, Waxmonsky J. Randomized controlled pilot study of Life Goals Collaborative Care for patients with bipolar disorder and cardiovascular disease risk from community-based practices. Psychiatr Serv. 2012; In press. doi:10.1176/
  14. 14.
    Kilbourne AM, Neumann MS, Waxmonsky J, Bauer MS, Kim HM, Pincus HA, et al. Public-academic partnerships: evidence-based implementation: the role of sustained community-based practice and research partnerships. Psychiatr Serv. 2012;63(3):205–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Bauer MS, Leader D, Un H, Lai Z, Kilbourne AM. Primary care and behavioral health practice size: the challenge for health care reform. Med Care. 2012.Google Scholar
  16. 16.
    • Woltmann E, Grogan-Kaylor A, Perron B, Georges H, Kilbourne AM, Bauer MS. Comparative effectiveness of collaborative chronic care models for mental health conditions across primary, specialty, and behavioral health care settings: systematic review and meta-analysis. Am J Psychiatry. 2012. A systematic review and meta-analysis of the effectiveness of collaboratve chronic care modesls for mental health conditions to improve health outcomes acrosss a variety of treatment settings. CCMs were found effective for improving depressive symptoms, mental and physical quality of life, and social role function across settings and disorders and CCMs were also found to be cost neutral including for treatment of bipolar disorder. Google Scholar
  17. 17.
    Goodrich DE, Kilbourne AM, Lai Z, Post EP, Bowersox NW, Mezuk B, et al. Design and rationale of a randomized controlled trial to reduce cardiovascular disease risk for patients with bipolar disorder. Contemp Clin Trials. 2012;33(4):666–78.PubMedCrossRefGoogle Scholar
  18. 18.
    Williams MD, Shah ND, Wagie AE, Wood DL, Frye MA. Direct costs of bipolar disorder versus other chronic conditions: an employer-based health plan analysis. Psychiatr Serv. 2011;62(9):1073–8.PubMedCrossRefGoogle Scholar
  19. 19.
    • Hsieh MH, Tang CH, Hsieh MH, Lee IH, Lai TJ, Lin YJ et al. Medical costs and vasculometabolic comorbidities among patients with bipolar disorder in Taiwan—a population-based and matched-control study. J Affect Disord. 2012. This national study of Tawainese patients diagnosed with bipolar disorder found total medical costs that were 11 fold greater than matched controls without a bipolar diagnosis. Non-psychiatric medical costs were 1.7 times higher in bipolar patients compared to controls and driven by a greater burnden of vasculometabolic morbidity which led to recommendations for greater preventive and integrated care for this population. Google Scholar
  20. 20.
    Sussman M, Friedman M, Korn JR, Hassan M, Kim J, Menzin J. The relationship between use of antidepressants and resource utilization among patients with manic or mixed bipolar disorder episodes: findings from a managed care setting. J Affect Disord. 2012;138(3):425–32.PubMedCrossRefGoogle Scholar
  21. 21.
    Druss BG, von Esenwein SA, Compton MT, Zhao L, Leslie DL. Budget impact and sustainability of medical care management for persons with serious mental illnesses. Am J Psychiatry. 2011;168(11):1171–8.PubMedGoogle Scholar
  22. 22.
    Hayes J, Prah P, Nazareth I, King M, Walters K, Petersen I, et al. Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995–2009. PLoS One. 2011;6(12):e28725.PubMedCrossRefGoogle Scholar
  23. 23.
    Stephenson JJ, Tuncelli O, Gu T, Eisenberg D, Panish J, Crivera C, et al. Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians’ perceptions of adherence vs. pharmacy claims. Int J Clin Pract. 2012;66(6):565–73.PubMedCrossRefGoogle Scholar
  24. 24.
    Dubovsky SL, Leonard K, Griswold K, Daurignac E, Hewitt B, Fox C, et al. Bipolar disorder is common in depressed primary care patients. Postgrad Med. 2011;123(5):129–33.PubMedCrossRefGoogle Scholar
  25. 25.
    • Rouillon F, Gasquet I, Garay RP, Lancrenon S. Impact of an educational program on the management of bipolar disorder in primary care. Bipolar Disord. 2011;13(3):318–22. This observational cohort study found that general practitioner participation in an educational program desiged to improve the diagnosis and treatment of bipolar depression was associated with an increase in differential diagnosis of bipolar depression, an increase in prescription of mood stabilizers, and a reduction in anti-depresseants compared to practitioners who did not undergo the educational program. PubMedCrossRefGoogle Scholar
  26. 26.
    Sansone RA, Forbis JS, Sosa T. Primary care perspectives on treating bipolar disorder: a cross-sectional survey. The primary care companion to CNS disorders. 2011;13(2).Google Scholar
  27. 27.
    Sansone RA, Sansone LA. Managing bipolar disorder in the primary care setting: a perspective for mental health professionals. Innov Clin Neurosci. 2011;8(10):10–3.Google Scholar
  28. 28.
    •• Malhi GS, Bargh DM, Cashman E, Frye MA, Gitlin M. The clinical management of bipolar disorder complexity using a stratified model. Bipolar Disord. 2012;14 Suppl 2:66–89. A practical and stratified treatment model is presented with the goal of helping providers in routine care settings understand and better treat, the complex presentations of bipolar disorder that are often overlooked in research and clinical guidelines.PubMedCrossRefGoogle Scholar
  29. 29.
    • Price AL, Marzani-Nissen GR. Bipolar disorders: a review. Am Fam Physician. 2012;85(5):483–93. A succint summary of evidence-based treatment practices and issues related to the treatment of bipolar disorder in primary care settings that was written from the perspective of a primary care provider. PubMedGoogle Scholar
  30. 30.
    Ramasubbu R, Taylor VH, Samaan Z, Sockalingham S, Li M, Patten S, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions. Ann Clin Psychiatry. 2012;24(1):91–109.PubMedGoogle Scholar
  31. 31.
    McIntyre RS, Schaffer A, Beaulieu S. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid conditions. Ann Clin Psychiatry. 2012;24(1):2–3.PubMedGoogle Scholar
  32. 32.
    Schaffer A, McIntosh D, Goldstein BI, Rector NA, McIntyre RS, Beaulieu S, et al. The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders. Ann Clin Psychiatry. 2012;24(1):6–22.PubMedGoogle Scholar
  33. 33.
    Bond DJ, Hadjipavlou G, Lam RW, McIntyre RS, Beaulieu S, Schaffer A, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder. Ann Clin Psychiatry. 2012;24(1):23–37.PubMedGoogle Scholar
  34. 34.
    Rosenbluth M, Macqueen G, McIntyre RS, Beaulieu S, Schaffer A, Canadian Network for M, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid personality disorders. Ann Clin Psychiatry. 2012;24(1):56–68.PubMedGoogle Scholar
  35. 35.
    McIntyre RS, Alsuwaidan M, Goldstein BI, Taylor VH, Schaffer A, Beaulieu S, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders. Ann Clin Psychiatry. 2012;24(1):69–81.PubMedGoogle Scholar
  36. 36.
    Chiu JF, Chokka PR. Prevalence of Bipolar Disorder symptoms in Primary Care (ProBiD-PC): a Canadian study. Can Fam Physician. 2011;57(2):e58–67.PubMedGoogle Scholar
  37. 37.
    • Culpepper L. Does screening for depression in primary care improve outcome? Curr Psychiatry Rep. 2012. A succinct history of depression screening and treatment in primary care settings that makes a compelling case for better integrating screening, diagnosis, and treatment of medical and psychiatric conditions. Google Scholar
  38. 38.
    Houston JP, Kroenke K, Faries DE, Doebbeling CC, Adler LA, Ahl J, et al. A provisional screening instrument for four common mental disorders in adult primary care patients. Psychosomatics. 2011;52(1):48–55.PubMedCrossRefGoogle Scholar
  39. 39.
    Kessler RC, Wang PS. The descriptive epidemiology of commonly occurring mental disorders in the United States. Annu Rev Public Health. 2008;29:115–29.PubMedCrossRefGoogle Scholar
  40. 40.
    Mark TL, Levit KR, Buck JA. Datapoints: psychotropic drug prescriptions by medical specialty. Psychiatr Serv. 2009;60(9):1167.PubMedCrossRefGoogle Scholar
  41. 41.
    Angst J, Cui L, Swendsen J, Rothen S, Cravchik A, Kessler RC, et al. Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication. Am J Psychiatry. 2010;167(10):1194–201.PubMedCrossRefGoogle Scholar
  42. 42.
    Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68(3):241–51.PubMedCrossRefGoogle Scholar
  43. 43.
    Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007;64(5):543–52.PubMedCrossRefGoogle Scholar
  44. 44.
    Dilsaver SC. An estimate of the minimum economic burden of bipolar I and II disorders in the United States: 2009. J Affect Disord. 2011;129(1–3):79–83.PubMedCrossRefGoogle Scholar
  45. 45.
    Bryant-Comstock L, Stender M, Devercelli G. Health care utilization and costs among privately insured patients with bipolar I disorder. Bipolar Disord. 2002;4:398–405.PubMedCrossRefGoogle Scholar
  46. 46.
    • De Hert M, Cohen D, Bobes J, Cetkovich-Bakmas M, Leucht S, Ndetei DM, et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry. 2011;10(2):138–51. Consensus recommendations from European health organizations that stress the importance of treating physical illness among persons with serious mental illnesses including recommendations on how to improve health outcomes for common physical health comorbidities in this population by considering system- and individual-level barriers to accessing care. PubMedGoogle Scholar
  47. 47.
    Weiner M, Warren L, Fiedorowicz JG. Cardiovascular morbidity and mortality in bipolar disorder. Ann Clin Psychiatry. 2011;23(1):40–7.PubMedGoogle Scholar
  48. 48.
    Calkin CV, Gardner DM, Ransom T, Alda M. The relationship between bipolar disorder and type 2 diabetes: more than just co-morbid disorders. Ann Med. 2012.Google Scholar
  49. 49.
    Sala R, Goldstein BI, Morcillo C, Liu SM, Castellanos M, Blanco C. Course of comorbid anxiety disorders among adults with bipolar disorder in the U.S. population. J Psychiatr Res. 2012;46(7):865–72.PubMedCrossRefGoogle Scholar
  50. 50.
    Provencher MD, Guimond AJ, Hawke LD. Comorbid anxiety in bipolar spectrum disorders: a neglected research and treatment issue? J Affect Disord. 2012;137(1–3):161–4.PubMedCrossRefGoogle Scholar
  51. 51.
    Judd LL, Schettler PJ, Akiskal H, Coryell W, Fawcett J, Fiedorowicz JG, et al. Prevalence and clinical significance of subsyndromal manic symptoms, including irritability and psychomotor agitation, during bipolar major depressive episodes. J Affect Disord. 2012;138(3):440–8.PubMedCrossRefGoogle Scholar
  52. 52.
    Novick DM, Swartz HA, Frank E. Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence. Bipolar Disord. 2010;12(1):1–9.PubMedCrossRefGoogle Scholar
  53. 53.
    Chen EH, Bodenheimer T. Improving population health through team-based panel management: comment on “Electronic medical record reminders and panel management to improve primary care of elderly patients”. Arch Intern Med. 2011;171(17):1558–9.PubMedCrossRefGoogle Scholar
  54. 54.
    Katon W. Collaborative depression care models: from development to dissemination. Am J Prev Med. 2012;42(5):550–2.PubMedCrossRefGoogle Scholar
  55. 55.
    Smith DJ, Thapar A, Simpson S. Bipolar spectrum disorders in primary care: optimising diagnosis and treatment. Br J Gen Pract. 2010;60(574):322–4.PubMedCrossRefGoogle Scholar
  56. 56.
    Stensland MD, Schultz JF, Frytak JR. Depression diagnoses following the identification of bipolar disorder: costly incongruent diagnoses. BMC Psychiatry. 2010;10:39.PubMedCrossRefGoogle Scholar
  57. 57.
    Smith DJ, Griffiths E, Kelly M, Hood K, Craddock N, Simpson SA. Unrecognised bipolar disorder in primary care patients with depression. Br J Psychiatry. 2011.Google Scholar
  58. 58.
    • Mitchell AJ. Clinical utility of screening for clinical depression and bipolar disorder. Curr Opin Psychiatry. 2012;25(1):24–31. A review of the utility of commonly used screening tools for depression and bipolar depression that concludes that tools for bipolar disorder are not yet accurate enough to be used widely in clinical practice and that more sophisticated tools are needed. PubMedGoogle Scholar
  59. 59.
    Zimmerman M, Galione JN, Ruggero CJ, Chelminski I, Dalrymple K, Young D. Are screening scales for bipolar disorder good enough to be used in clinical practice? Compr Psychiatry. 2011;52(6):600–6.PubMedCrossRefGoogle Scholar
  60. 60.
    Parker G, Fletcher K, Blanch B, Greenfield L. Take-up and profile of individuals accessing a web-based bipolar self-test screening measure. J Affect Disord. 2012;138(1–2):117–22.PubMedCrossRefGoogle Scholar
  61. 61.
    Ng F, Mammen OK, Wilting I, Sachs GS, Ferrier IN, Cassidy F, et al. The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord. 2009;6:559–95.CrossRefGoogle Scholar
  62. 62.
    Beaulieu S, Saury S, Sareen J, Tremblay J, Schutz CG, McIntyre RS, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders. Ann Clin Psychiatry. 2012;24(1):38–55.PubMedGoogle Scholar
  63. 63.
    Ramasubbu R, Beaulieu S, Taylor VH, Schaffer A, McIntyre RS, Canadian Network for M, et al. The CANMAT task force recommendations for the management of patients with mood disorders and comorbid medical conditions: diagnostic, assessment, and treatment principles. Ann Clin Psychiatry. 2012;24(1):82–90.PubMedGoogle Scholar
  64. 64.
    Yatham LN, Kennedy SH, O’Donovan C, Parikh SV, MacQueen G, McIntyre RS, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disord. 2006;8(6):721–39.PubMedCrossRefGoogle Scholar
  65. 65.
    Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q. 1996;74(4):511–44.PubMedCrossRefGoogle Scholar
  66. 66.
    Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288(14):1775–9.PubMedCrossRefGoogle Scholar
  67. 67.
    Bauer MS, McBride L, Williford WO, Glick H, Kinosian B, Altshuler L, et al. Collaborative care for bipolar disorder: part II. Impact on clinical outcome, function, and costs. Psychiatr Serv. 2006;57(7):937–45.PubMedCrossRefGoogle Scholar
  68. 68.
    Simon GE, Ludman EJ, Bauer MS, Unutzer J, Operskalski B. Long-term effectiveness and cost of a systematic care program for bipolar disorder. Arch Gen Psychiatry. 2006;63(5):500–8.PubMedCrossRefGoogle Scholar
  69. 69.
    Kilbourne AM, Post EP, Nossek A, Drill L, Cooley S, Bauer MS. Improving medical and psychiatric outcomes among individuals with bipolar disorder: a randomized controlled trial. Psychiatr Serv. 2008;59(7):760–8.PubMedCrossRefGoogle Scholar
  70. 70.
    Bauer MS, Leader D, Un H, Lai Z, Kilbourne AM. Primary care and behavioral health practice size: the challenge for healthcare reform. Med Care. 2012; In press. doi:10.1097/MLR.0b013e31825f2864.
  71. 71.
    Lieberman DZ, Swayze S, Goodwin FK. An automated Internet application to help patients with bipolar disorder track social rhythm stabilization. Psychiatr Serv. 2011;62(11):1267–9.PubMedCrossRefGoogle Scholar
  72. 72.
    Todd NJ, Solis-Trapala I, Jones SH, Lobban FA. An online randomised controlled trial to assess the feasibility, acceptability and potential effectiveness of ‘Living with Bipolar’: a web-based self-management intervention for bipolar disorder: trial design and protocol. Contemp Clin Trials. 2012;33(4):679–88.PubMedCrossRefGoogle Scholar
  73. 73.
    Lauder S, Chester A, Castle D, Dodd S, Berk L, Klein B, et al. Development of an online intervention for bipolar disorder. Psychol Health Med. 2012.
  74. 74.
    Todd NJ, Jones SH, Lobban FA. What do service users with bipolar disorder want from a web-based self-management intervention? A Qualitative Focus Group Study. Clin Psychol Psychother. 2012.Google Scholar
  75. 75.
    Simon GE, Ludman EJ, Goodale LC, Dykstra DM, Stone E, Cutsogeorge D, et al. An online recovery plan program: can peer coaching increase participation? Psychiatr Serv. 2011;62(6):666–9.PubMedCrossRefGoogle Scholar
  76. 76.
    Miklowitz DJ, Price J, Holmes EA, Rendell J, Bell S, Budge K, et al. Facilitated integrated mood management for adults with bipolar disorder. Bipolar Disord. 2012;14(2):185–97.PubMedCrossRefGoogle Scholar
  77. 77.
    Bauer MS, McBride L, Williford WO, Glick H, Kinosian B, Altshuler L, et al. Collaborative care for bipolar disorder: part I. Intervention and implementation in a randomized effectiveness trial. Psychiatr Serv. 2006;57(7):927–36.PubMedCrossRefGoogle Scholar
  78. 78.
    Kilbourne AM, Post EP, Nossek A, Sonel E, Drill LJ, Cooley S, et al. Service delivery in older patients with bipolar disorder: a review and development of a medical care model. Bipolar Disord. 2008;10(6):672–83.PubMedCrossRefGoogle Scholar
  79. 79.
    Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck Jr PE, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000;157(11):1873–5.PubMedCrossRefGoogle Scholar
  80. 80.
    Hirschfeld RM, Calabrese JR, Weissman MM, Reed M, Davies MA, Frye MA, et al. Screening for bipolar disorder in the community. J Clin Psychiatry. 2003;64(1):53–9.PubMedCrossRefGoogle Scholar
  81. 81.
    Hirschfeld RM, Cass AR, Holt DC, Carlson CA. Screening for bipolar disorder in patients treated for depression in a family medicine clinic. J Am Board Fam Pract. 2005;18:233–9.PubMedCrossRefGoogle Scholar
  82. 82.
    Miller CJ, Klugman J, Berv DA, Rosenquist KJ, Ghaemi SN. Sensitivity and specificity of the Mood Disorder Questionnaire for detecting bipolar disorder. J Affect Disord. 2004;81:167–71.PubMedCrossRefGoogle Scholar
  83. 83.
    Nassir Ghaemi S, Miller CJ, Berv DA, Klugman J, Rosenquist KJ, Pies RW. Sensitivity and specificity of a new bipolar spectrum diagnostic scale. J Affect Disord. 2005;84(2–3):273–7.PubMedCrossRefGoogle Scholar
  84. 84.
    Angst J, Adolfsson R, Benazzi F, Gamma A, Hantouche E, Meyer TD, et al. The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. J Affect Disord. 2005;88:217–33.PubMedCrossRefGoogle Scholar
  85. 85.
    Vieta E, Sanchez-Moreno J, Bulbena A, Chamorro L, Ramos JL, Artal J, et al. Cross validation with the mood disorder questionnaire (MDQ) of an instrument for the detection of hypomania in Spanish: the 32 item hypomania symptom check list (HCL-32). J Affect Disord. 2007;101:43–55.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC (outside the USA) 2012

Authors and Affiliations

  • Amy M. Kilbourne
    • 1
    • 2
  • David E. Goodrich
    • 1
    • 2
  • Allison N. O’Donnell
    • 1
  • Christopher J. Miller
    • 3
  1. 1.VA Ann Arbor Center for Clinical Management ResearchAnn ArborUSA
  2. 2.Department of PsychiatryUniversity of Michigan Medical SchoolAnn ArborUSA
  3. 3.Center for Organization, Leadership, & Management ResearchVA Boston Healthcare SystemBostonUSA

Personalised recommendations